Expertise in Blood and Bone Marrow Transplant

The Stanford Blood and Marrow Transplant Program combines twenty-five years of treatment expertise with state-of-the-art research and comprehensive support services to assure the best possible outcomes for our patients. Offering treatment for a variety of malignant and non-malignant diseases, including lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected solid tumors, the Blood and Marrow Transplant Program strives for full reintegration of each patient into normal, everyday life. 

Blood and Bone Marrow Transplant Program
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-723-0822 Getting Here
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-723-0822 Getting Here

Our Doctors

Care and Treatment at Stanford

Blood and Bone Marrow Transplantation Types

There are several types of blood and bone marrow transplants depending on who serves as the donor. The source of the hematopoietic (blood forming) cells further defines the type of transplant. The hematopoietic cells used for transplantation can be collected from the blood or the bone marrow. Hematopoietic cells, sometimes referred to as blood stem cells, are immature cells capable of dividing and developing into any type of mature blood cells.

Allogeneic transplant

Using donor cells to provide patients with new blood cells and a new immune system after cancer treatment.

Autologous transplant

Using an infusion of a patient's own cells to restore the body's ability to make healthy blood cells.

Blood and bone marrow transplant

A specialized therapy to transfer healthy bone marrow cells into a patient after their own unhealthy bone marrow has been eliminated.

Stem cell transplant for cancers

A method of replacing blood-forming cells destroyed by cancer treatment to help the bone marrow recover and continue to make healthy blood cells.

Expanded treatment options

Traditional transplantation methods are being advanced at Stanford to help all of our patients. These modified approaches include autologous transplantation followed by a reduced intensity allogeneic transplant, the use of a haploidentical donor, graft selection techniques, cellular therapy, monoclonal antibodies and vaccinations, and new treatment approaches for many diseases, including our protocol for mycosis fungoides.

If you are considering a transplant, your Stanford Blood and Marrow Transplant Program doctor will discuss which options could be most beneficial to you.

Clinical Trials

Stanford's cutting-edge research

The following is some of the research that Blood and Marrow Transplant Program doctors have recently been involved with:

  • Cellular therapeutics—translational research investigating specific cell populations, such as regulatory T-cells, cytokine induced killer (CIK) cells, tumor vaccines, and memory T-cells
  • Graft vs host disease—investigating novel approaches to the prevention and treatment of graft vs host disease
  • Haploidentical hematopoietic (blood forming) cell transplantation
  • Pioneered novel TLI/ATG allogeneic preparative regimen, which reduces rates of graft vs host disease and lowers transplant-related risks in select disease types

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all blood and marrow transplant eligibility flowcharts at the Stanford Cancer Institute.

For Patients


Review the New Patient Packet for information about:

  • What to expect on the day of your appointment
  • Maps, directions, parking, public transit options, and contact information
  • Other patient resources

The initial evaluation process begins with a referral from your hematologist or oncologist to a Stanford Blood and Marrow Transplantation Program doctor. After this referral, the Stanford Blood and Marrow Transplant Program new patient coordinator will call you with an appointment date and time.

Bring completed forms found in the BMT New Patient Letter.


Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care (formerly Stanford Hospital & Clinics). 

International Patients
Phone: +1 650-723-8561

For Health Care Professionals


Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.

Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.


To refer a patient, call our Stanford Blood and Marrow Transplantation Program office at 650-723-0822.

Track your patients' progress and communicate with Stanford providers securely online.

Learn More About PRISM »